2,320
Views
19
CrossRef citations to date
0
Altmetric
Clinical Study

Biomarker evidence for distal tubular damage but cortical sparing in hospitalized diabetic patients with acute kidney injury (AKI) while on SGLT2 inhibitors

, , , , , , & show all
Pages 836-844 | Received 26 Mar 2020, Accepted 20 Jul 2020, Published online: 13 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

JunYuan Bai, XiaoWei Pu, YunXia Zhang & Enlai Dai. (2022) Renal tubular gene biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis. Renal Failure 44:1, pages 966-986.
Read now
Xuyan Liu, Huasheng Du, Yan Sun & Leping Shao. (2022) Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention. Renal Failure 44:1, pages 790-805.
Read now

Articles from other publishers (16)

Jericho Wee, Xiang Ren Tan, Samuel H. Gunther, Mohammed Ihsan, Melvin Khee Shing Leow, Doreen Su-Yin Tan, Johan G. Eriksson & Jason Kai Wei Lee. (2023) Effects of Medications on Heat Loss Capacity in Chronic Disease Patients: Health Implications Amidst Global Warming. Pharmacological Reviews 75:6, pages 1140-1166.
Crossref
Melpomeni Peppa, Aspasia Manta, Ioanna Mavroeidi, Athina Asimakopoulou, Alexandros Syrigos, Constantinos Nastos, Emmanouil Pikoulis & Anastasios Kollias. (2023) Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus. Pharmaceutics 15:11, pages 2526.
Crossref
Edoardo Gronda, Alberto Palazzuoli, Massimo Iacoviello, Manuela Benevenuto, Domenico Gabrielli & Arduino Arduini. (2023) Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe?. International Journal of Molecular Sciences 24:12, pages 9957.
Crossref
E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, E. I. Surikova, I. V. Neskubina, Yu. A. Pogorelova, L. K. Trepitaki, N. D. Cheryarina, I. M. Kotieva & M. I. Morozova. (2022) Insulin-like growth factors and their carrier proteins in kidneys of rats with experimental diabetes, malignant tumor, and their combination. Bulletin of Siberian Medicine 21:3, pages 112-119.
Crossref
Samuel N. Heyman, Itamar Raz, Jamie P. Dwyer, Roni Weinberg Sibony, Julia B. Lewis & Zaid Abassi. (2022) Diabetic Proteinuria Revisited: Updated Physiologic Perspectives. Cells 11:18, pages 2917.
Crossref
. (2022) Gliflozins in the Management of Cardiovascular Disease. New England Journal of Medicine 387:5, pages 477-478.
Crossref
Gang Chen, Xiaolin Li, Quexuan Cui, Yangzhong Zhou, Bin Zhao, Dan Mei & Xuemei. (2022) Acute kidney injury following SGLT2 inhibitors among diabetic patients: a pharmacovigilance study. International Urology and Nephrology 54:11, pages 2949-2957.
Crossref
Marta Greco, Eusebio Chiefari, Maria Mirabelli, Alessandro Salatino, Vera Tocci, Paola Cianfrone, Daniela Patrizia Foti & Antonio Brunetti. (2022) Plasma or Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL): Which Is Better at Detecting Chronic Kidney Damage in Type 2 Diabetes?. Endocrines 3:2, pages 175-186.
Crossref
André J Scheen & Pierre Delanaye. (2022) Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers. Diabetes & Metabolism 48:2, pages 101315.
Crossref
Ashish Kataria & Christos Argyropoulos. 2022. Diabetes and Kidney Disease. Diabetes and Kidney Disease 533 561 .
Ajinath Kale, Himanshu Sankrityayan, Hans-Joachim Anders & Anil Bhanudas Gaikwad. (2021) Klotho: A possible mechanism of action of SGLT2 inhibitors preventing episodes of acute kidney injury and cardiorenal complications of diabetes. Drug Discovery Today 26:8, pages 1963-1971.
Crossref
Michele Provenzano, Maria Chiara Pelle, Isabella Zaffina, Bruno Tassone, Roberta Pujia, Marco Ricchio, Raffaele Serra, Angela Sciacqua, Ashour Michael, Michele Andreucci & Franco Arturi. (2021) Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge. Frontiers in Medicine 8.
Crossref
Lior Lupu, Keren-Lee Rozenfeld, David Zahler, Samuel Morgan, Ilan Merdler, Moshe Shtark, Ilana Goldiner, Shmuel Banai & Yacov Shacham. (2021) Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker. Journal of Clinical Medicine 10:10, pages 2120.
Crossref
Holger Scholz, Felix J. Boivin, Kai M. Schmidt-Ott, Sebastian Bachmann, Kai-Uwe Eckardt, Ute I. Scholl & Pontus B. Persson. (2021) Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection. Nature Reviews Nephrology 17:5, pages 335-349.
Crossref
Samuel N. Heyman, Thomas Walther & Zaid Abassi. (2021) Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic. Journal of Clinical Medicine 10:6, pages 1200.
Crossref
Samuel N. Heyman, Michael Bursztyn & Zaid Abassi. (2020) Low‐salt diet and renal safety: taken with a pinch of salt. The Journal of Physiology 598:23, pages 5299-5300.
Crossref